Crossref

1. Comment on ‘Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study’

- Seyed M. Alavian

- Heidar Sharafi

2. Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting

- Heidar Sharafi

- Hossein Poustchi

- Fatemeh Azimian

- Babak Tamadoni

- Rashid Ramezani

- Mohamad Mehdi Gouya

- Mahdi Sheikh

- Farnaz Hashemi

- Mehrzad Tashakorian

- Ramin Alasvand

- Seyed Moayed Alavian

- Shahin Merat

3. Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders

- Heidar Sharafi

- Bita Behnava

- Alireza Azizi-saraji

- Ali Namvar

- Ali Anvar

- Shima Salimi

- Seyed Moayed Alavian

4. Effectiveness of generic direct-acting agents for the treatment of hepatitis C: systematic review and meta-analysis

- Hugo Perazzo

- Rodolfo Castro

- Paula M Luz

- Mariana Banholi

- Rafaela V Goldenzon

- Sandra W Cardoso

- Beatriz Grinsztejn

- Valdilea G Veloso

5. Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study

- Mohammad Tasavon Gholamhoseini

- Heidar Sharafi

- Helena HL Borba

- Seyed Moayed Alavian

- Asma Sabermahani

- Behzad Hajarizadeh

6. Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?

- Heidar Sharafi

- Seyed Moayed Alavian

7. Treatment of HCV Infection with Direct-Acting Antiviral Agents in Patients with HIV/HCV Co-Infection: A Systematic Review

- Saman Mohazzab-Torabi

- Fardin Dolatimehr

- Heidar Sharafi

- Mahdi Safi-Abadi

- Mohammad Saeid Rezaee-Zavareh

- Ehsan Bayatpour

- Hamidreza Karimi-Sari

- Seyed Moayed Alavian

8. Prevalence of hepatitis C virus NS5A resistance-associated substitutions in chronic infection with genotype 1: A pooled analysis based on deposited sequences in GenBank

- Heidar Sharafi

- Saeideh Maleki

- Seyed Moayed Alavian

9. Pooled Prevalence of NS5A Resistance-Associated Substitutions in Chronic HCV Genotype 3 Infection: A Study Based on Deposited Sequences in GenBank

- Heidar Sharafi

- Saman Ghalamkari

- Alireza Hassanshahi

- Seyed Moayed Alavian

10. Seroprevalence of Hepatitis C Virus among Blood Donors in Middle Eastern Countries: A Systematic Review and Meta-Analysis

- Hossein Ghaderi-Zefrehi

- Heidar Sharafi

- Farzin Sadeghi

- Mohammad Gholami-Fesharaki

- Alireza Farasat

- Fatemeh Jahanpeyma

- Seyed Moayed Alavian

11. Hepatitis C virus infection in Iran: A review of current prevalence and preventive strategies from a developing country

- Marcarious M. Tantuoyir

- Muhammed Camara

- Marjan Sohrabi

- SeyedAhmad SeyedAlinaghi

- Zahra Ahmadinejad

12. Update on Recommendations for the Clinical Management of Hepatitis C in Iran 2017

- Seyed Moayed Alavian

- Heidar Sharafi